News
But behind the carefully built persona was Eli Cohen, an Israeli spy feeding crucial secrets to his homeland. Sixty years ago, his double life ended with a public execution. This week, Israel ...
Media Capital Technologies (MCT) and The Horror Section will fully finance and produce “Ice Cream Man,” Eli Roth’s new horror film. Roth, a master of the genre whose work includes the ...
Despite beating on its earnings Thursday, pharma giant Eli Lilly (LLY) suffered a nearly 12% loss in its stock, losing more than $90 billion in market cap in a single day. "We think the market ...
IMX price skyrockets 44% As Ethereum, XRP and Solana all eye key levels, IMX leads the top 100 by market with a parabolic spike to highs of $0.69, its highest level since March 28.
IMX has surged by nearly 35% in the past week. The token is rallying today after the project’s co-founder shared exciting news about Immutable Passport. IMX needs to break above $0.620 to keep ...
Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions ...
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. By Rebecca Robbins and Gina Kolata Encouraging ...
Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...
The Immutable (IMX) token rose around 15% on March 25 to reach just under $0.74 shortly after the firm announced that the SEC shut its inquiry without any breach of violations, which Immutable ...
Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results